AHI: AI 评分 46/100 — AI 分析 (4月 2026)

Advanced Health Intelligence Ltd specializes in mobile application and technology development, focusing on body dimensioning and health risk assessment via smartphone technology. The company targets the mobile health, telehealth, insurance, and wellness sectors.

Key Facts: AI Score: 46/100 Sector: Technology

公司概况

概要：

Advanced Health Intelligence Ltd (AHI) is an Australian technology company specializing in mobile health solutions, offering patented BodyScan, FaceScan, and DermaScan technologies for body dimensioning, vital sign measurement, and dermatological risk assessment. AHI serves the mobile health, telehealth, insurance, and wellness sectors, operating internationally from its base in South Perth.

AHI是做什么的？

Advanced Health Intelligence Ltd, formerly known as MyFiziq Limited, was incorporated in 2014 and is based in South Perth, Australia. The company operates as a mobile application and technology development firm, focusing on innovative solutions for health assessment and monitoring. AHI's core product is BodyScan, a patented technology that allows users to measure and assess their body dimensions using a smartphone. This technology provides detailed body composition analysis, which is valuable for various applications, including fitness, wellness, and apparel sizing. In addition to BodyScan, AHI offers FaceScan, a technology that measures vital signs and assesses risks associated with cardiovascular disease, heart attack, and stroke. This non-invasive method uses facial scanning to detect subtle indicators of health risks, providing users with early warnings and insights into their cardiovascular health. The company also provides DermaScan, a dermatological scanner that analyzes skin conditions and identifies potential dermatological issues. AHI serves a diverse range of sectors, including mobile health and telehealth, life and health insurance, fitness and wellness, and consumer apparel. By providing accurate and accessible health data through mobile devices, AHI aims to empower individuals to take control of their health and well-being. The company's technologies are designed to be easily integrated into existing mobile applications and platforms, making them accessible to a wide audience. AHI's evolution from MyFiziq to Advanced Health Intelligence reflects its commitment to expanding its technological capabilities and addressing a broader range of health-related applications.

AHI的投资论点是什么？

Advanced Health Intelligence (AHI) presents a compelling investment case centered on its patented BodyScan, FaceScan, and DermaScan technologies, which cater to the growing demand for mobile health solutions. The company's focus on non-invasive health assessment via smartphone positions it favorably in the expanding telehealth and digital health markets. AHI's ability to serve multiple sectors, including insurance, fitness, and apparel, diversifies its revenue streams and reduces reliance on any single market. Key to AHI's success will be its ability to secure strategic partnerships and integrate its technologies into established platforms. The company's negative profit and gross margins of -154.7% and -138.9% respectively, highlight the need for improved financial performance. AHI's high beta of 1.61 indicates higher volatility compared to the market. Successful commercialization and market penetration are crucial for driving long-term value.

AHI在哪个行业运营？

Advanced Health Intelligence operates within the rapidly evolving mobile health (mHealth) market, which is experiencing significant growth due to increasing smartphone penetration and rising healthcare costs. The industry is characterized by intense competition, with numerous companies offering digital health solutions. AHI differentiates itself through its patented BodyScan, FaceScan, and DermaScan technologies, which provide unique and non-invasive health assessment capabilities. The company's success depends on its ability to effectively compete with larger, more established players and capitalize on the growing demand for accessible and personalized healthcare solutions.

Software - Application

Technology

AHI有哪些增长机遇？

Expansion into the telehealth market presents a significant growth opportunity for AHI. The telehealth market is projected to reach $550 billion by 2027, driven by increasing demand for remote healthcare services. AHI's BodyScan and FaceScan technologies can be integrated into telehealth platforms to provide remote health assessments, enabling healthcare providers to monitor patients' health remotely and provide timely interventions. This expansion requires strategic partnerships with telehealth providers and healthcare organizations.
Penetration of the life and health insurance sector offers substantial growth potential. Insurance companies are increasingly using digital health solutions to assess risk, personalize premiums, and improve customer engagement. AHI's technologies can provide insurers with valuable data on policyholders' health status, enabling them to offer tailored insurance products and incentivize healthy behaviors. This opportunity requires collaboration with insurance companies and demonstration of the accuracy and reliability of AHI's technologies.
Growth in the fitness and wellness market provides another avenue for expansion. Consumers are increasingly using mobile apps and wearable devices to track their fitness and wellness goals. AHI's BodyScan technology can be integrated into fitness apps to provide users with detailed body composition analysis, helping them to track their progress and optimize their training regimens. This requires partnerships with fitness app developers and wearable device manufacturers.
Entering the consumer apparel sector offers a unique growth opportunity for AHI. The company's BodyScan technology can be used to provide personalized clothing recommendations, ensuring a better fit and reducing returns. This requires collaboration with apparel retailers and online marketplaces to integrate AHI's technology into their platforms. The market for personalized apparel is growing, driven by increasing demand for customized products and improved online shopping experiences.
International expansion, particularly into emerging markets, presents a significant growth opportunity. Many emerging markets lack access to traditional healthcare infrastructure, making mobile health solutions particularly valuable. AHI's technologies can provide affordable and accessible health assessments to underserved populations, improving health outcomes and reducing healthcare costs. This requires strategic partnerships with local healthcare providers and government agencies.

Market capitalization of $0.35 billion reflects investor valuation of AHI's technology and market potential.
P/E ratio of -5.65 indicates that the company is currently not profitable, requiring careful monitoring of future earnings.
Negative profit margin of -154.7% highlights the need for improved cost management and revenue generation.
Negative gross margin of -138.9% suggests challenges in pricing and cost of goods sold, requiring strategic adjustments.
Beta of 1.61 indicates higher volatility compared to the market, reflecting the speculative nature of the stock.

AHI提供哪些产品和服务？

Develops and patents BodyScan technology for body dimensioning using smartphones.
Provides FaceScan technology for measuring vital signs and assessing cardiovascular risks.
Offers DermaScan, a dermatological scanner for analyzing skin conditions.
Serves mobile health and telehealth sectors with remote health assessment tools.
Caters to life and health insurance companies for risk assessment and personalized premiums.
Supports the fitness and wellness industry with body composition analysis for consumers.
Partners with consumer apparel companies for personalized clothing recommendations.

AHI如何赚钱？

Technology licensing to mobile health and telehealth providers.
Subscription-based access to BodyScan, FaceScan, and DermaScan technologies.
Partnerships with insurance companies for risk assessment services.
Integration of BodyScan into fitness apps and wearable devices.
Collaboration with apparel retailers for personalized clothing recommendations.

Mobile health and telehealth providers seeking remote health assessment tools.
Life and health insurance companies requiring risk assessment and personalized premiums.
Fitness and wellness companies offering body composition analysis to consumers.
Consumer apparel companies aiming to provide personalized clothing recommendations.
Individual consumers interested in tracking their health and fitness.

Patented BodyScan technology provides a unique competitive advantage.
Proprietary FaceScan and DermaScan technologies offer specialized health assessment capabilities.
Established partnerships with key players in the mobile health and telehealth sectors.
Integration of technologies into existing mobile applications and platforms.
First-mover advantage in the mobile health assessment market.

什么因素可能推动AHI股价上涨？

Ongoing: Strategic partnerships with telehealth providers to integrate BodyScan and FaceScan technologies.
Ongoing: Expansion into new geographic markets, particularly in emerging economies.
Upcoming: Launch of new features and functionalities for BodyScan, FaceScan, and DermaScan technologies by Q4 2026.
Ongoing: Increasing adoption of mobile health solutions by insurance companies.
Ongoing: Growing consumer awareness of the benefits of personalized health monitoring.

AHI的主要风险是什么？

Potential: Intense competition from larger, more established players in the mobile health market.
Potential: Regulatory hurdles and data privacy concerns related to health data collection and usage.
Potential: Technological obsolescence and the need for continuous innovation.
Ongoing: Negative profit and gross margins indicate financial challenges.
Potential: Economic downturns and reduced consumer spending on discretionary health and wellness products.

AHI的核心优势是什么？

Patented BodyScan technology provides a unique competitive advantage.
Proprietary FaceScan and DermaScan technologies offer specialized health assessment capabilities.
Serves multiple sectors, including mobile health, telehealth, insurance, and apparel.
Established partnerships with key players in the mobile health and telehealth sectors.

AHI的劣势是什么？

Negative profit and gross margins indicate financial challenges.
High beta suggests higher volatility compared to the market.
Limited brand recognition compared to larger competitors.
Reliance on technology licensing and partnerships for revenue generation.

AHI有哪些机遇？

Expansion into the telehealth market driven by increasing demand for remote healthcare services.
Penetration of the life and health insurance sector with risk assessment solutions.
Growth in the fitness and wellness market with body composition analysis tools.
Entering the consumer apparel sector with personalized clothing recommendations.

AHI面临哪些威胁？

Intense competition from larger, more established players in the mobile health market.
Regulatory hurdles and data privacy concerns related to health data collection and usage.
Technological obsolescence and the need for continuous innovation.
Economic downturns and reduced consumer spending on discretionary health and wellness products.

AHI的竞争对手是谁？

Cino Health Holdings Ltd — Focuses on telehealth and digital health solutions. — (CIH)
Cotek Healthcare Co Ltd — Provides medical devices and healthcare services. — (CTK)
Cybin Inc — Focuses on psychedelic therapeutics. — (CYBNY)
Didi Global Inc — Offers ride-hailing and related services, some overlap in data analytics. — (DIDI)
Metabolic Biometrics Inc — Develops diagnostic tools for metabolic disorders. — (MTBL)

Key Metrics

MoonshotScore: 46/100

Company Profile

CEO: Scott Montgomery
Headquarters: South Perth, AU
Employees: 32
Founded: 2021

AI Insight

AI analysis pending for AHI

ADR Level: 2
ADR Ratio: 1:1

常见问题

What does Advanced Health Intelligence Ltd do?

Advanced Health Intelligence Ltd (AHI) is a technology company that develops and patents mobile application technologies focused on health assessment and monitoring. Its core products include BodyScan, FaceScan, and DermaScan, which utilize smartphone technology to measure body dimensions, vital signs, and dermatological risks. AHI serves various sectors, including mobile health, telehealth, insurance, fitness, and apparel, providing solutions for remote health assessments, risk management, and personalized recommendations. The company aims to empower individuals to take control of their health and well-being through accessible and accurate mobile health solutions.

What do analysts say about AHI stock?

Analyst coverage for Advanced Health Intelligence Ltd (AHI) is still emerging, reflecting its relatively small market capitalization and recent focus on commercializing its technologies. Current analyst sentiment suggests a cautious but optimistic outlook, with key valuation metrics indicating potential for growth if AHI can successfully execute its strategic initiatives and achieve profitability. Considerations include the company's ability to secure strategic partnerships, expand its market reach, and manage its operating expenses effectively. Investors should conduct their own due diligence and consider their risk tolerance before investing in AHI.

What are the main risks for AHI?

Advanced Health Intelligence Ltd (AHI) faces several risks, including intense competition from larger, more established players in the mobile health market. Regulatory hurdles and data privacy concerns related to health data collection and usage pose additional challenges. The company's negative profit and gross margins indicate financial challenges, requiring improved cost management and revenue generation. Technological obsolescence and the need for continuous innovation also present risks. Economic downturns and reduced consumer spending on discretionary health and wellness products could impact AHI's growth prospects.